Skip to main content
Premium Trial:

Request an Annual Quote

Sistemic to Apply miRNA Platform to Standardize Stem Cell Manufacturing


Sistemic, a microRNA services firm based in Glasgow, UK, has signed an agreement with Roslin Cells that aims to standardize the manufacture of stem cells for use in cell therapy and drug development screening.

Under the terms of the agreement, Roslin will use Sistemic's SistemQC service, which applies miRNA profiling to monitor stem cell identity, safety, and differentiation staging.

Aidan Courtney, CEO of Roslin, said in a statement that the characterization of both primary tissue and of cells in culture is "fundamental to our operation" and "underpins our ability to produce the highest possible quality of cells for use in cell therapies and as research tools."

He added that the collaboration with Sistemic "will enable us to improve our production processes and deliver more extensive and valuable data to those using our cells.”

The Scan

Not as High as Hoped

The Associated Press says initial results from a trial of CureVac's SARS-CoV-2 vaccine suggests low effectiveness in preventing COVID-19.

Finding Freshwater DNA

A new research project plans to use eDNA sampling to analyze freshwater rivers across the world, the Guardian reports.

Rise in Payments

Kaiser Health News investigates the rise of payments made by medical device companies to surgeons that could be in violation of anti-kickback laws.

Nature Papers Present Ginkgo Biloba Genome Assembly, Collection of Polygenic Indexes, More

In Nature this week: a nearly complete Ginkgo biloba genome assembly, polygenic indexes for dozens of phenotypes, and more.